| scholarly article | Q13442814 |
| P50 | author | Michael J Boivin | Q54239405 |
| Mutsa Bwakura-Dangarembizi | Q57875617 | ||
| Barbara Laughton | Q61160991 | ||
| Avy Violari | Q91877369 | ||
| P2093 | author name string | Mark F Cotton | |
| Miriam C Chernoff | |||
| Linda Barlow-Mosha | |||
| Hermien Gous | |||
| Portia Kamthunzi | |||
| Bonnie Zimmer | |||
| Lee Fairlie | |||
| Paul E Palumbo | |||
| Itziar Familiar-Lopez | |||
| Katie McCarthy | |||
| Patrick Jean-Phillippe | |||
| Joan Coetzee | |||
| Celeste Joyce | |||
| Mmule Ratswana | |||
| Nasreen Abrahams | |||
| IMPAACT P1104s Study Team | |||
| P2860 | cites work | Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. | Q30370395 |
| Socioeconomic predictors of cognition in Ugandan children: implications for community interventions | Q30912436 | ||
| HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children | Q33893123 | ||
| A preliminary examination of the construct validity of the KABC-II in Ugandan children with a history of cerebral malaria. | Q33918629 | ||
| A pilot study of the neuropsychological benefits of computerized cognitive rehabilitation in Ugandan children with HIV. | Q34134863 | ||
| Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission | Q34200009 | ||
| ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects | Q34202181 | ||
| Antiretroviral treatment for children with peripartum nevirapine exposure | Q34494986 | ||
| Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a | Q34718135 | ||
| Use of the Behavior Rating Inventory of Executive Function and Child Behavior Checklist in Ugandan Children with HIV or a History of Severe Malaria | Q35554042 | ||
| Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts | Q35815274 | ||
| Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure | Q36071395 | ||
| Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence | Q36179611 | ||
| Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children | Q36238419 | ||
| The role of weight for age and disease stage in poor psychomotor outcome of HIV-infected children in Kilifi, Kenya | Q36678438 | ||
| A year-long caregiver training program to improve neurocognition in preschool Ugandan HIV-exposed children | Q36847401 | ||
| Caregivers' depressive symptoms and parent-report of child executive function among young children in Uganda | Q36882378 | ||
| Neurodevelopment in perinatally HIV-infected children: a concern for adolescence | Q36941655 | ||
| Paediatric HIV and neurodevelopment in sub-Saharan Africa: a systematic review | Q37126779 | ||
| A year-long caregiver training program improves cognition in preschool Ugandan children with human immunodeficiency virus | Q37266061 | ||
| Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system | Q37390163 | ||
| Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo | Q37456754 | ||
| CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory. | Q37557899 | ||
| Designing and evaluating Brain Powered Games for cognitive training and rehabilitation in at-risk African children | Q37609353 | ||
| Randomized controlled trial of caregiver training for HIV-infected child neurodevelopment and caregiver well being | Q38671486 | ||
| Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children | Q38851296 | ||
| Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial. | Q38853723 | ||
| Socio-demographic correlates of depression and anxiety among female caregivers living with HIV in rural Uganda | Q38854374 | ||
| A Randomized Controlled Trial to Evaluate if Computerized Cognitive Rehabilitation Improves Neurocognition in Ugandan Children with HIV. | Q38855116 | ||
| Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children | Q38879795 | ||
| A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children | Q38913504 | ||
| CNS Impact of Perinatal HIV Infection and Early Treatment: the Need for Behavioral Rehabilitative Interventions Along with Medical Treatment and Care | Q38991265 | ||
| HIV-Associated Cognitive Impairment in Perinatally Infected Children: A Meta-analysis | Q39035580 | ||
| Cross-cultural assessment of HIV-associated cognitive impairment using the Kaufman assessment battery for children: a systematic review | Q39406562 | ||
| The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions | Q39946534 | ||
| Factors associated with the health and cognition of 6-year-old to 8-year-old children in KwaZulu-Natal, South Africa | Q40299699 | ||
| Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. | Q40812757 | ||
| Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers. | Q42219111 | ||
| Neurocognitive function profile in HIV-infected school-age children | Q44247552 | ||
| Evaluating a ten questions screen for childhood disability: reliability and internal structure in different cultures | Q47203423 | ||
| The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory | Q69729597 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuropsychology | Q3872 |
| P304 | page(s) | 189-204 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial | |
| P478 | volume | 32 |
| Q90676952 | Beyond Their HIV Status: the Occurrence of Multiple Health Risk Behavior Among Adolescents from a Rural Setting of Sub-Saharan Africa |
| Q56910457 | Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing |
| Q54239357 | Neurocognitive testing in West African children 3-6 years of age: Challenges and implications for data analyses. |
| Q63677379 | Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa |
| Q60049131 | Prevalence of chronic kidney disease-associated pruritus, and association with sleep quality among hemodialysis patients in Pakistan |
| Q56969729 | Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration |
| Q93143599 | The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis in Pakistan: A STROBE complaint cross-sectional study |
| Q61453838 | The role of the home environment in neurocognitive development of children living in extreme poverty and with frequent illnesses: a cross-sectional study |
| Q56909890 | Validity of Neuropsychological Testing in Young African Children Affected by HIV |
Search more.